We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
86 hedge funds and large institutions have $225M invested in Atossa Therapeutics in 2021 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
889% more capital invested
Capital invested by funds: $22.8M → $225M (+$203M)
200% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 7
157% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 21
62% more funds holding
Funds holding: 53 → 86 (+33)
17% more call options, than puts
Call options by funds: $84M | Put options by funds: $71.8M
0.96% more ownership
Funds ownership: 1.01% → 1.97% (+0.96%)
Holders
86
Holders Change
+33
Holders Change %
+62.26%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
54
Increased
21
Reduced
7
Closed
21
Calls
$84M
Puts
$71.8M
Net Calls
+$12.2M
Net Calls Change
+$6.5M
Top Buyers
| 1 |
BlackRock
New York
|
+$26.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.11M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.98M |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.17M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$6.53M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$6.97M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$912K |
| 3 |
VF
Virtu Financial
New York
|
-$894K |
| 4 |
Barclays
London,
United Kingdom
|
-$150K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$120K |
